Medicamen Biotech Ltd logo

Medicamen Biotech Ltd

MEDICAMEQ NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹311 Cr
Volatility
Moderate
P/E Ratio
28.5
EBITDA
₹19.59 Cr
Return on Equity
3.08%
Debt to Equity
0.17
Book Value
₹203.17
EPS
₹5.81
52W High
₹447.65
52W Low
₹212.4

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medicamen Biotech Ltd insights

39 extracted metrics + investor summaries across FY17–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

2
  • Stock is trading at 1.11 times its book value
  • Company is expected to give good quarter

Weaknesses

4
  • The company has delivered a poor sales growth of 11.9% over past five years.
  • Company has a low return on equity of 4.23% over last 3 years.
  • Dividend payout has been low at 14.5% of profits over last 3 years
  • Company has high debtors of 151 days.

Growth Rate

Revenue Growth
17.16% ↗
Net Income Growth
42.88% ↗
Cash Flow Change
-21.07% ↘
ROE
-32.90% ↗
ROCE
-28.49% ↗
EBITDA Margin (Avg.)
-18.14% ↗

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
41.94
43.54
46.5
47.32
43.05
44.74
45.14
29.61
43.04
47.17
46.91
60.65
47.9
Expenses
34.99
38.89
41.6
41.57
39.6
39.43
38.43
31.22
38.43
42.01
42.53
55.22
43.57
Operating Profit
6.95
4.65
4.9
5.75
3.45
5.31
6.71
-1.61
4.61
5.16
4.38
5.43
4.33
OPM %
16.57%
10.68%
10.54%
12.15%
8.01%
11.87%
14.86%
-5.44%
10.71%
10.94%
9.34%
8.95%
9.04%
Other Income
0.38
0.55
0.83
0.57
0.59
0.29
0.14
5.23
0.47
0.37
0.53
1.74
0.86
Interest
0.96
0.91
0.65
1.89
0.71
1.04
0.76
0.65
1.15
0.99
0.97
0.38
0.83
Depreciation
1.69
1.82
1.8
1.77
1.77
2.61
2.21
0.48
1.8
1.86
1.83
1.73
1.79
PBT
4.68
2.47
3.28
2.66
1.56
1.95
3.88
2.49
2.13
2.68
2.11
5.06
2.57
Tax %
15.81%
39.68%
38.11%
22.93%
48.72%
53.85%
24.74%
25.3%
24.88%
21.27%
22.27%
12.06%
28.4%
Net Profit
3.95
1.47
2.03
2.04
0.8
0.91
2.92
1.87
1.6
2.12
1.64
4.45
1.85
EPS in Rs
3.3
1.19
1.9
1.68
1.06
1.15
2.73
1.9
1.59
1.97
1.61
2.85
1.56
Figures in ₹ Crores

Profit & Loss

  Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
123
125
113
115
141
179
163
198
203
Expenses
105
106
93
91
117
156
148
178
183
Operating Profit
17
20
20
24
24
24
14
20
19
OPM %
14%
16%
17%
21%
17%
13%
9%
10%
10%
Other Income
4
2
1
2
2
2
6
3
4
Interest
1
1
2
2
3
6
4
4
3
Depreciation
2
2
3
6
6
7
7
7
7
PBT
18
18
16
18
17
13
10
12
12
Tax %
31%
26%
26%
18%
14%
27%
34%
18%
—
Net Profit
12
13
12
15
15
9
7
10
10
EPS in Rs
10.28
10.88
9.93
12.2
11.73
8.6
5.59
7.11
7.99
Div. Payout %
10%
5%
10%
8%
9%
12%
18%
14%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12
12
12
12
13
13
13
14
Reserves
75
109
121
134
181
194
200
262
Borrowings
12
11
19
26
26
31
34
48
Other Liabilities
38
49
42
53
59
56
50
49
Total Liabilities
137
181
194
226
279
295
297
372
Fixed Assets
24
34
90
92
93
92
87
85
CWIP
15
40
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
Other Assets
97
107
104
133
186
203
210
287
Total Assets
137
181
194
226
279
295
297
372
Figures in ₹ Crores

Cash Flow

  Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
13
13
4
-6
-7
-8
-33
Investing
-15
-37
-18
-8
-6
-6
-1
-3
Financing
-4
19
6
4
29
6
-1
64
Net Cash Flow
-14
-5
1
0
17
-6
-11
28
Free Cash Flow
-11
-25
-5
-4
-13
-13
-10
-38
CFO/OP
48
88
88
30
-13
-16
-47
-159
Figures in ₹ Crores

Ratios

  Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
129
145
170
200
169
112
155
151
Inventory Days
67
78
27
188
228
234
268
251
Days Payable
134
173
169
302
241
154
184
144
Cash Conversion Cycle
62
51
28
86
156
193
239
259
Working Capital Days
116
130
126
147
156
123
186
193
ROCE %
—
16%
13%
12%
10%
8%
6%
5%

Shareholding Pattern

As of Jun 2026
Promoters 40.46%
Public 32.10%
Others 26.91%
DIIs 0.40%
FIIs 0.07%
Government 0.05%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Apr 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
44.83%
44.83%
44.83%
43.60%
43.60%
43.60%
43.21%
43.21%
43.21%
43.21%
43.21%
43.21%
43.21%
42.99%
42.99%
42.99%
43.16%
40.46%
40.46%
40.46%
40.46%
40.46%
40.46%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.21%
0.11%
0.06%
0.06%
0.05%
0.12%
0.22%
0.00%
0.06%
0.02%
0.10%
0.07%
DIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.13%
0.20%
0.20%
0.20%
0.00%
0.68%
0.99%
1.17%
1.17%
0.87%
0.69%
0.65%
0.64%
0.59%
0.44%
0.00%
0.40%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.06%
0.06%
0.05%
0.05%
0.05%
0.05%
0.05%
0.05%
Public
33.04%
32.97%
33.17%
34.23%
34.30%
35.02%
30.94%
31.35%
31.49%
31.43%
31.80%
31.90%
31.95%
31.57%
32.43%
32.96%
33.35%
31.58%
31.50%
33.35%
32.17%
32.09%
32.10%
Others
22.12%
22.20%
21.99%
22.18%
22.10%
21.38%
25.72%
25.24%
25.10%
25.16%
24.99%
24.00%
23.74%
24.21%
23.34%
23.08%
22.63%
27.04%
27.34%
25.50%
26.86%
27.30%
26.91%
No. of Shareholders
4,965
5,263
5,595
9,140
9,300
9,107
8,418
8,273
8,233
8,272
9,419
10,252
10,639
10,652
10,792
10,576
10,435
10,592
10,808
11,177
10,967
10,806
11,047

Documents

1
Concall - Jun 2020 Jun 2020
2
Concall - Aug 2020 Aug 2020
3
Concall - Nov 2020 Nov 2020
4
Concall - Dec 2021 Dec 2021
5
Concall - Nov 2024 Nov 2024

Frequently Asked Questions about Medicamen Biotech Ltd

What does Medicamen Biotech Ltd do?
Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]
Where is Medicamen Biotech Ltd (MEDICAMEQ) listed?
Medicamen Biotech Ltd is listed on the Indian stock exchanges. It is listed on NSE: MEDICAMEQ and BSE: 531146. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Medicamen Biotech Ltd belong to?
Medicamen Biotech Ltd operates in the Healthcare sector within the Pharmaceuticals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a market capitalisation of approximately ₹311.24 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Medicamen Biotech Ltd?
The Price-to-Earnings (PE) ratio of Medicamen Biotech Ltd is 28.50. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Medicamen Biotech Ltd?
Over the past 52 weeks, Medicamen Biotech Ltd has traded between a low of ₹212.4 and a high of ₹447.65. This range helps investors understand the stock's price volatility and recent trading levels.
Does Medicamen Biotech Ltd pay dividends?
Yes, Medicamen Biotech Ltd has a dividend yield of 0.44%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a Return on Equity (ROE) of 3.08%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Medicamen Biotech Ltd on Tapetide?
On Tapetide, you can view Medicamen Biotech Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]

Website medicamen.com
CEO Mr. Rajesh Madan B. Pharma
Employees 376
Listed 2005-01-12
Face Value ₹ 10
Issued Size 1,35,62,815

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List